Literature DB >> 23169677

Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy.

Gwendolyn S Kerby1, Brandie D Wagner, Jonathan Popler, Thomas C Hay, Carol Kopecky, Stephanie L Wilcox, Ralph R Quinones, Roger H Giller, Frank J Accurso, Robin R Deterding.   

Abstract

RATIONALE: Lung function in children with neuroendocrine cell hyperplasia of infancy (NEHI) and correlations with future clinical outcomes are needed to guide clinical management.
OBJECTIVE: To compare results of infant pulmonary function tests (IPFTs) in children with NEHI to disease control (DC) subjects and to correlate NEHI IPFTs with future outcomes.
METHODS: We performed a retrospective, single center study of IPFT in subjects diagnosed by lung biopsy (NEHI) or clinically (NEHI syndrome) and in DC subjects evaluated for cancer or pre-hematopoietic stem cell transplantation (HSCT). Raised volume rapid thoracoabdominal compression (RVRTC) and plethysmography were performed on all infants and evaluated for quality. Standard spirometry measures, room air oxygen saturations (RA O2 sat), and weight percentiles were collected during follow up.
MEASUREMENTS AND MAIN RESULTS: Fifty-seven IPFTs were performed in 15 NEHI, 22 NEHI syndrome, and 20 DC subjects. RVRTC and FRC measurements were obtained in 85% or more of subjects in all groups. Significant airflow limitation (FEV0.5 P-value ≤ 0.01) and air trapping (FRC P-value ≤ 0.01) were seen in NEHI and NEHI syndrome subjects compared to DCs. No significant correlations were found between IPFT, oxygen use, RA O2 sat, and weight at the time of the IPFTs. Initial FEV0.5 and FRC z-scores correlated with RA O2 sat (r = 0.60 and -0.49) at short-term follow up (6-12 months). Most measurements of RVRTC correlated with FEV1 (n = 5) measured 4-5 years later (r > 0.50).
CONCLUSIONS: IPFTs in NEHI subjects are feasible, demonstrate significant obstruction and air trapping, and correlate with future RA O2 sat and FEV1 . IPFTs may provide valuable clinical information when caring for NEHI patients. Pediatr Pulmonol. 2013; 48:1008-1015.
© 2012 Wiley Periodicals, Inc. © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  children's interstitial lung disease; hypoxemia; infant pulmonary function; neuroendocrine cell; pediatric diffuse lung disease

Mesh:

Year:  2012        PMID: 23169677     DOI: 10.1002/ppul.22718

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  18 in total

1.  Rare Becomes More Common: Recognizing Neuroendocrine Cell Hyperplasia of Infancy in Everyday Pulmonary Consultations.

Authors:  Michael Glenn O'Connor; Mark Wurth; Lisa R Young
Journal:  Ann Am Thorac Soc       Date:  2015-11

2.  A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy.

Authors:  Lisa R Young; Gail H Deutsch; Ronald E Bokulic; Alan S Brody; Lawrence M Nogee
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

Review 3.  Childhood interstitial lung diseases: an 18-year retrospective analysis.

Authors:  Jennifer J Soares; Gail H Deutsch; Paul E Moore; Mohammad F Fazili; Eric D Austin; Rebekah F Brown; Andrew G Sokolow; Melissa A Hilmes; Lisa R Young
Journal:  Pediatrics       Date:  2013-09-30       Impact factor: 7.124

4.  Lung and airway shape in neuroendocrine cell hyperplasia of infancy.

Authors:  Emily J Mastej; Emily M DeBoer; Stephen M Humphries; Marlijne C Cook; Kendall S Hunter; Deborah R Liptzin; Jason P Weinman; Robin R Deterding
Journal:  Pediatr Radiol       Date:  2018-06-28

Review 5.  Interstitial lung disease in children.

Authors:  Christin S Kuo; Lisa R Young
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

6.  Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities.

Authors:  Deborah R Liptzin; Kaci Pickett; John T Brinton; Amit Agarwal; Martha P Fishman; Alicia Casey; Christopher T Towe; Jane B Taylor; Geoffrey Kurland; James S Hagood; Jennifer Wambach; Ruma Srivastava; Hani Al-Saleh; Sharon D Dell; Lisa R Young; Robin R Deterding
Journal:  Ann Am Thorac Soc       Date:  2020-06

7.  Pulmonary Aptamer Signatures in Children's Interstitial and Diffuse Lung Disease.

Authors:  Robin R Deterding; Brandie D Wagner; J Kirk Harris; Emily M DeBoer
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

8.  High-resolution CT findings of pulmonary interstitial glycogenosis.

Authors:  Jason P Weinman; Christina J White; Deborah R Liptzin; Robin R Deterding; Csaba Galambos; Lorna P Browne
Journal:  Pediatr Radiol       Date:  2018-04-23

9.  Growth trajectories and oxygen use in neuroendocrine cell hyperplasia of infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; Deneen A Schaudies; Lisa R Young
Journal:  Pediatr Pulmonol       Date:  2018-02-02

10.  Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; John A Worrell; Ronald L Morton; Lawrence M Nogee; Timothy S Blackwell; Lisa R Young
Journal:  Ann Am Thorac Soc       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.